Cargando…

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2

Monoclonal antibodies targeting the SARS‐CoV‐2 spike (S) neutralize infection and are efficacious for the treatment of COVID‐19. However, SARS‐CoV‐2 variants, notably sublineages of B.1.1.529/omicron, have emerged that escape antibodies in clinical use. As an alternative, soluble decoy receptors bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lianghui, Narayanan, Krishna K, Cooper, Laura, Chan, Kui K, Skeeters, Savanna S, Devlin, Christine A, Aguhob, Aaron, Shirley, Kristie, Rong, Lijun, Rehman, Jalees, Malik, Asrar B, Procko, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539395/ https://www.ncbi.nlm.nih.gov/pubmed/36094679 http://dx.doi.org/10.15252/emmm.202216109

Ejemplares similares

An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2
por: Zhang, Lianghui, et al.
Publicado: (2022)

Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
por: Zhang, Lianghui, et al.
Publicado: (2022)

Machine learning guided design of high affinity ACE2 decoys for SARS-CoV-2 neutralization
por: Chan, Matthew C., et al.
Publicado: (2021)

Computationally engineered ACE2 decoy binds with nanomolar affinity with the SARS-CoV-2 spike protein
por: Islam, Mohammad S., et al.
Publicado: (2022)

Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 Variants
por: Zhang, Lianghui, et al.
Publicado: (2021)

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
por: Chan, Kui K., et al.
Publicado: (2021)

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
por: Chan, Kui K., et al.
Publicado: (2020)

A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo
por: Havranek, Brandon, et al.
Publicado: (2023)

Interleukin-1RA Mitigates SARS-CoV-2–Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice
por: Xiong, Shiqin, et al.
Publicado: (2021)

An ACE2-Based Decoy Inhibitor Effectively Neutralizes SARS-CoV-2 Omicron BA.5 Variant
por: Zhang, Haoran, et al.
Publicado: (2022)

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo
por: Ikemura, Nariko, et al.
Publicado: (2022)

High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses
por: Sims, Joshua J., et al.
Publicado: (2022)

Engineering ACE2 decoy receptors to combat viral escapability
por: Arimori, Takao, et al.
Publicado: (2022)

A decoy mutant ACE2 designed to reduce COVID-19
por: Maishan, Mazharul, et al.
Publicado: (2022)

The Sequence Basis for Selectivity of Ephrin-B2 Ligand for Eph Receptors and Pathogenic Henipavirus G Glycoproteins: Selective Ephrin-B2 Decoys for Nipah and Hendra Virus
por: Narayanan, Krishna K., et al.
Publicado: (2023)

SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells
por: Zhang, Lianghui, et al.
Publicado: (2017)

Outsmarting SARS-CoV-2 by empowering a decoy ACE2
por: Sokolowska, Milena
Publicado: (2020)

Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation
por: Jambusaria, Ankit, et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Sox17 is required for endothelial regeneration following inflammation-induced vascular injury
por: Liu, Menglin, et al.
Publicado: (2019)

Inhaled platelet vesicle-decoyed biomimetic nanoparticles attenuate inflammatory lung injury
por: Jin, Hua, et al.
Publicado: (2022)

Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants
por: Tang, Haoneng, et al.
Publicado: (2022)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection
por: Ching, Krystal L., et al.
Publicado: (2022)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Mechanosensing Piezo channels in tissue homeostasis including their role in lungs
por: Zhong, Ming, et al.
Publicado: (2018)

DecoyFinder, a tool for finding decoy molecules
por: Adrià, Cereto Massagué, et al.
Publicado: (2012)

Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
por: Mysinger, Michael M., et al.
Publicado: (2012)

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
por: Linsky, Thomas W., et al.
Publicado: (2020)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Tanaka, Shiho, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Remarks on the Proper Mode of Administering Sulphuric Ether by Inhalation
Publicado: (1847)

Generation of enzymatically competent SARS‐CoV‐2 decoy receptor ACE2‐Fc in glycoengineered Nicotiana benthamiana
por: Castilho, Alexandra, et al.
Publicado: (2021)

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
por: Capraz, Tümay, et al.
Publicado: (2021)

Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model
por: Tada, Takuya, et al.
Publicado: (2023)

A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells
por: Kegler, Alexandra, et al.
Publicado: (2023)

Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection
por: Lu, Mengjia, et al.
Publicado: (2023)

Deep Mutational Scanning of Viral Glycoproteins and Their Host Receptors
por: Narayanan, Krishna K., et al.
Publicado: (2021)

Notch1 promotes ordered revascularization through Semaphorin 3g modulation of downstream vascular patterning signalling factors
por: Hyun, James, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4p0efcpl7f63a2qik598hhs11